Please check your internet connection and try again.
# Arsil-DX
## Overview
Arsil-DX is a fixed-dose combination product containing **Guaifenesin** (expectorant) and **Dextromethorphan HBr** (antitussive). It is indicated for the temporary relief of coughs due to minor throat and bronchial irritation associated with the common cold or inhaled irritants.
## Primary Indications
Symptomatic relief of productive cough and non-productive cough associated with upper respiratory tract infections.
## Adult Dosing
* **Standard Dose:** 20 mL (containing guaifenesin 400 mg/dextromethorphan 20 mg) orally every 4 hours.
* **Maximum Dose:** 120 mL (2400 mg guaifenesin/120 mg dextromethorphan) per 24 hours.
## Pediatric Dosing
* **Children 12 years and older:** Same as adult dosing.
* **Children 6 to 11 years:** 10 mL orally every 4 hours; maximum 60 mL per 24 hours.
* **Children under 6 years:** Use is generally not recommended unless under the direct supervision of a healthcare provider. Follow local institutional protocols for specific age-based weight-band dosing.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific adjustments provided by the manufacturer, but caution is advised in patients with severe impairment.
* **Elderly:** Start at the lower end of the dosing range due to increased risk of dizziness and confusion.
## Contraindications
* Hypersensitivity to guaifenesin, dextromethorphan, or any excipients.
* Concurrent use (or use within 14 days) of Monoamine Oxidase Inhibitors (MAOIs).
* Chronic cough associated with asthma, emphysema, or smoking (unless directed by a physician).
## Adverse Effects
* **Common:** Dizziness, drowsiness, nausea, vomiting, or stomach pain.
* **Serious:** Severe allergic reactions (rash, swelling), Serotonin Syndrome (with overdosage or interaction with serotonergic agents), and confusion.
## Key Drug Interactions
* **MAOIs:** Risk of hypertensive crisis, hyperpyrexia, and serotonin syndrome.
* **CNS Depressants (Alcohol, Sedatives, Antihistamines):** Potentiates sedative effects.
* **Serotonergic Agents (SSRIs, SNRIs, Triptans):** Increased risk of Serotonin Syndrome when combined with dextromethorphan.
## Monitoring
* Monitor for symptom progression (if cough persists > 7 days, recurs, or is accompanied by fever, rash, or persistent headache).
* Assess for signs of CNS depression or abuse potential (dextromethorphan).
## Clinical Pearls
* Ensure patients identify the specific concentration of the product, as "DX" combinations can vary by brand.
* Guaifenesin is most effective when taken with a full glass of water to help loosen bronchial secretions.
* Dextromethorphan should be avoided in patients with a persistent cough or "smoker’s cough" where suppression may be counterproductive to clearing airways.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify current prescribing information, local clinical protocols, and patient-specific factors via reliable clinical databases (e.g., Lexicomp, Micromedex) or the official package insert prior to prescribing or administration.
